Abstract
The camptothecins are a new class of chemotherapeutic agents which have a novel mechanism of action targeting the nuclear enzyme topoisomerase I. Knowledge of the structure-activity relationships of the parent compound camptothecin has led to the development of effective soluble analogues with manageable toxicities. Broad anti-tumour activity shown in preclinical studies has been confirmed in phase I/II studies for irinotecan and topotecan. Two other derivatives, 9-aminocamptothecin and GI 147211C, are undergoing phase I and early phase II evaluation. Although camptothecin is a plant extract, it and most of its derivatives are not affected by the classic P-gpMDR1 mechanism of resistance which may allow the development of novel combination chemotherapeutic regimens. Important areas of future endeavour will include the development of rational combination regimens and the pursuit of randomised trials. Based on single agent data, colorectal cancer and non-small-cell lung cancer should be the focus for future irinotecan studies. Small-cell lung cancer and ovarian carcinoma are logical tumour types to pursue with topotecan. Both 9-aminocamptothecin and GI 147211C are too early in their clinical evaluation to make recommendations about their future roles. Finally, the unfolding story of camptothecin analogue development will give important insights into the predictive value of preclinical observations on relative efficacy, schedule dependency, combination strategies and resistance mechanisms which have helped determine the strategies for clinical evaluation of these agents.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dancey, J., Eisenhauer, E. Current perspectives on camptothecins in cancer treatment. Br J Cancer 74, 327–338 (1996). https://doi.org/10.1038/bjc.1996.362
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.362
This article is cited by
-
Bioactive Molecules of Endophytic Fungi and Their Potential in Anticancer Drug Development
Current Pharmacology Reports (2021)
-
Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species
Scientific Reports (2017)
-
Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
Cancer Chemotherapy and Pharmacology (2016)
-
Microscopic modes and free energies for topoisomerase I-DNA covalent complex binding with non-camptothecin inhibitors by molecular docking and dynamics simulations
Theoretical Chemistry Accounts (2013)
-
Interaction of human serum albumin with 10-hydroxycamptothecin: spectroscopic and molecular modeling studies
Molecular Biology Reports (2012)